NPPA notified regarding the fixation of the retail price of Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg for M/s Skymap Pharmaceuticals Pvt. Ltd. (Manufacturer & Marketer)

Mar 15, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 12, 2025, notified regarding the fixation of the retail price of Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg for M/s Skymap Pharmaceuticals Pvt. Ltd. (Manufacturer & Marketer).

It has fixed the rate at Rs. 19.64/- for each film coated tablets containing: Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg for M/s Skymap Pharmaceuticals Pvt. Ltd. (Manufacturer & Marketer).


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT